Oracle shares climbed 2.9% to EUR 126.50 on Friday, lifted by a broader relief rally across US technology names after weaker-than-expected American jobs data eased rate concerns. The soft payroll figures, reported by Reuters and AP, pulled capital back into rate-sensitive megacap stocks and handed Oracle a welcome reprieve after months of selling pressure.
That bounce, however, is only half the story. Beneath the day-to-day tape, the software and cloud group is asking investors to underwrite a costly transformation — one that pits aggressive infrastructure spending against the need to convert capacity promises into recurring software and platform revenue.
Jupiter’s Shadow Recedes
Much of Friday’s improved mood traced back to Project Jupiter, the New Mexico data center campus at the heart of Oracle’s AI infrastructure buildout. Late in September, the company served a force majeure notice on developer STACK Infrastructure, a subsidiary of private equity investor Blue Owl, citing potential delays in securing the power capacity the site requires. According to Reuters, the move preserved Oracle’s option to defer payments should construction stall, even as the company insisted the project remained on schedule.
The campus is designed to draw as much as 2.45 gigawatts — a staggering power load that has made it a lightning rod for questions about how the industry funds and energizes its largest builds. A flood recently reached the site, though Oracle said critical infrastructure escaped damage. With the initial shockwaves absorbed, sentiment has begun to firm.
Power, Nuclear and a Pending Verdict
Securing electricity has become a strategic priority in its own right. On Friday, Oracle announced it would take a portion of the output from the Point Beach nuclear plant, an arrangement expected to save the utility’s Wisconsin customers roughly USD 300 million in fuel costs. The deal remains subject to approval from the Wisconsin Public Service Commission, whose decision now stands as a key near-term catalyst.
Should investors sell immediately? Or is it worth buying Oracle?
The Product Offensive
On the commercial front, Oracle is moving quickly to give its infrastructure spending somewhere to land. The company recently unveiled Fusion Claw, a runtime environment for agentic AI applications, backed by 25 applications built on top of it. It also extended its financial-crime portfolio with agentic capabilities under the names Oracle Nexus Case Flow and Oracle Nexus Reach.
A partnership with NetApp will add a fully managed cloud storage service for demanding AI and enterprise workloads running on Oracle’s own infrastructure. In healthcare, a memorandum of understanding with the King Faisal Specialist Hospital & Research Centre to link clinical and genomic data signals the company’s ambition to anchor specialized industry solutions profitably.
Ownership, Analyst Support and the Road Ahead
Wall Street offered its own vote of confidence. Citizens reiterated its Market Outperform rating on Friday with a USD 285 price target. Insider activity added to the mix: board member Stephen Rusckowski purchased 25,000 shares on September 29. A current voting-rights filing shows founder Larry Ellison holding 1,158,375,174 shares, or 38.2% of the share class.
The central question remains whether Oracle can monetize its technology positioning fast enough to justify the heavy upfront outlays. Prolonged investment cycles or stalled megaprojects would strain profitability under rising fixed costs. Holding the recent level keeps the consolidation thesis alive; a durable breakout would require clarity on the large data center builds and broad customer adoption of the new AI tools. Should sentiment sour again — or fresh power-infrastructure delays disrupt major contracts — the stock could retest lower support. Even after stabilizing, the shares remain down 24% year to date.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from October 3 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 3.
Oracle: Buy or sell? Read more here...
